Cytokinetics: Q4 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Cytokinetics Inc. (CYTK) on Wednesday reported a loss of $137.1 million in it...
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Cytokinetics Inc. (CYTK) on Wednesday reported a loss of $137.1 million in its fourth quarter. The South San Francisco, California-based company said it had a loss of $1.45 per share. The results fell short of Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.22 per share. The biopharmaceutical company posted revenue of $2 million in the period, also missing Street forecasts.